Diana F. Hausman - 08 May 2023 Form 3 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Role
Director
Signature
/s/ Andrea Paul, attorney-in-fact for Diana Hausman
Issuer symbol
ZNTL
Transactions as of
08 May 2023
Net transactions value
$0
Form type
3
Filing time
10 May 2023, 07:11:34 UTC
Previous filing
23 Jun 2022
Next filing
15 Jun 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney